

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Golgi transport vesicle coating (GO:0048200) | 4.50537562 |
| 2 | COPI coating of Golgi vesicle (GO:0048205) | 4.50537562 |
| 3 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.46406411 |
| 4 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.46406411 |
| 5 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 4.07730223 |
| 6 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.86289373 |
| 7 | protein retention in ER lumen (GO:0006621) | 3.73851229 |
| 8 | protein localization to endosome (GO:0036010) | 3.65515174 |
| 9 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.64855395 |
| 10 | barbed-end actin filament capping (GO:0051016) | 3.58173010 |
| 11 | response to peptidoglycan (GO:0032494) | 3.47613883 |
| 12 | pentose-phosphate shunt (GO:0006098) | 3.46038471 |
| 13 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.33674308 |
| 14 | DNA deamination (GO:0045006) | 3.32436438 |
| 15 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.28217807 |
| 16 | cell adhesion mediated by integrin (GO:0033627) | 3.25341443 |
| 17 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.21247120 |
| 18 | protein targeting to ER (GO:0045047) | 3.20658702 |
| 19 | ribosomal small subunit assembly (GO:0000028) | 3.19979173 |
| 20 | cotranslational protein targeting to membrane (GO:0006613) | 3.18483198 |
| 21 | signal peptide processing (GO:0006465) | 3.18390295 |
| 22 | NADPH regeneration (GO:0006740) | 3.17355658 |
| 23 | NIK/NF-kappaB signaling (GO:0038061) | 3.14753039 |
| 24 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.06055472 |
| 25 | protein localization to endoplasmic reticulum (GO:0070972) | 3.05597163 |
| 26 | folic acid metabolic process (GO:0046655) | 3.03712838 |
| 27 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.03658704 |
| 28 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 3.02567077 |
| 29 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.00998852 |
| 30 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.98093536 |
| 31 | COPII vesicle coating (GO:0048208) | 2.94038117 |
| 32 | negative regulation of phagocytosis (GO:0050765) | 2.92972134 |
| 33 | hypotonic response (GO:0006971) | 2.91877179 |
| 34 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.91686814 |
| 35 | viral transcription (GO:0019083) | 2.90388512 |
| 36 | positive regulation of nuclease activity (GO:0032075) | 2.90235386 |
| 37 | translational termination (GO:0006415) | 2.88796805 |
| 38 | regulation of vitamin metabolic process (GO:0030656) | 2.87826048 |
| 39 | 4-hydroxyproline metabolic process (GO:0019471) | 2.84576964 |
| 40 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.84434157 |
| 41 | actin nucleation (GO:0045010) | 2.82665390 |
| 42 | hyaluronan catabolic process (GO:0030214) | 2.78807251 |
| 43 | membrane raft organization (GO:0031579) | 2.77257484 |
| 44 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.75101064 |
| 45 | regulation of nuclease activity (GO:0032069) | 2.70074215 |
| 46 | serine family amino acid biosynthetic process (GO:0009070) | 2.69161506 |
| 47 | valine metabolic process (GO:0006573) | 2.68276485 |
| 48 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.67906011 |
| 49 | cysteine metabolic process (GO:0006534) | 2.67646181 |
| 50 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.67396002 |
| 51 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.66344649 |
| 52 | negative regulation of interleukin-12 production (GO:0032695) | 2.64265117 |
| 53 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 2.62885322 |
| 54 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 2.62885322 |
| 55 | translational elongation (GO:0006414) | 2.60711594 |
| 56 | negative regulation of necroptotic process (GO:0060546) | 2.59250096 |
| 57 | glycine metabolic process (GO:0006544) | 2.57526354 |
| 58 | cellular response to unfolded protein (GO:0034620) | 2.56964970 |
| 59 | cellular response to arsenic-containing substance (GO:0071243) | 2.55129059 |
| 60 | protein maturation by protein folding (GO:0022417) | 2.54423779 |
| 61 | embryonic process involved in female pregnancy (GO:0060136) | 2.53936151 |
| 62 | maternal placenta development (GO:0001893) | 2.53794820 |
| 63 | sequestering of metal ion (GO:0051238) | 2.51619990 |
| 64 | formation of translation preinitiation complex (GO:0001731) | 2.48681212 |
| 65 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.48257862 |
| 66 | skin morphogenesis (GO:0043589) | 2.46732102 |
| 67 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 2.46658657 |
| 68 | type I interferon signaling pathway (GO:0060337) | 2.45909000 |
| 69 | cellular response to type I interferon (GO:0071357) | 2.45909000 |
| 70 | cellular response to topologically incorrect protein (GO:0035967) | 2.43966173 |
| 71 | ER-nucleus signaling pathway (GO:0006984) | 2.43814936 |
| 72 | response to type I interferon (GO:0034340) | 2.42205337 |
| 73 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.41028985 |
| 74 | glucose catabolic process (GO:0006007) | 2.40918660 |
| 75 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.40091118 |
| 76 | germinal center formation (GO:0002467) | 2.39895223 |
| 77 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.39650461 |
| 78 | translational initiation (GO:0006413) | 2.39280871 |
| 79 | lipopolysaccharide biosynthetic process (GO:0009103) | 2.39155329 |
| 80 | positive regulation of macrophage differentiation (GO:0045651) | 2.39085631 |
| 81 | response to muramyl dipeptide (GO:0032495) | 2.38050779 |
| 82 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.37455477 |
| 83 | regulation of necroptotic process (GO:0060544) | 2.37323196 |
| 84 | T cell apoptotic process (GO:0070231) | 2.36608500 |
| 85 | modulation by symbiont of host cellular process (GO:0044068) | 2.36468517 |
| 86 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.34840421 |
| 87 | glycosphingolipid catabolic process (GO:0046479) | 2.34202675 |
| 88 | low-density lipoprotein particle clearance (GO:0034383) | 2.32162852 |
| 89 | * protein N-linked glycosylation via asparagine (GO:0018279) | 2.31945126 |
| 90 | response to laminar fluid shear stress (GO:0034616) | 2.31224353 |
| 91 | folic acid-containing compound metabolic process (GO:0006760) | 2.30653429 |
| 92 | positive regulation of B cell differentiation (GO:0045579) | 2.30179633 |
| 93 | DNA unwinding involved in DNA replication (GO:0006268) | 2.29692322 |
| 94 | * peptidyl-asparagine modification (GO:0018196) | 2.28642430 |
| 95 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.28359530 |
| 96 | stress fiber assembly (GO:0043149) | 2.28310237 |
| 97 | serine family amino acid metabolic process (GO:0009069) | 2.27398370 |
| 98 | viral life cycle (GO:0019058) | 2.26578509 |
| 99 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.26455338 |
| 100 | myeloid dendritic cell differentiation (GO:0043011) | 2.26443643 |
| 101 | nucleoside salvage (GO:0043174) | 2.26371481 |
| 102 | DNA strand elongation (GO:0022616) | 2.26229073 |
| 103 | regulation of necrotic cell death (GO:0010939) | 2.25827192 |
| 104 | tetrahydrofolate metabolic process (GO:0046653) | 2.25744347 |
| 105 | membrane protein ectodomain proteolysis (GO:0006509) | 2.25346704 |
| 106 | folic acid transport (GO:0015884) | 2.24145566 |
| 107 | nucleobase biosynthetic process (GO:0046112) | 2.24013758 |
| 108 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.23998080 |
| 109 | mature B cell differentiation involved in immune response (GO:0002313) | 2.22795820 |
| 110 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.22690203 |
| 111 | sulfur amino acid catabolic process (GO:0000098) | 2.21650300 |
| 112 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.21533845 |
| 113 | L-serine metabolic process (GO:0006563) | 2.21034198 |
| 114 | peptidyl-proline hydroxylation (GO:0019511) | 2.20855079 |
| 115 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.20077004 |
| 116 | protein targeting to membrane (GO:0006612) | 2.19331351 |
| 117 | apoptotic cell clearance (GO:0043277) | 2.19055978 |
| 118 | lipopolysaccharide metabolic process (GO:0008653) | 2.18832716 |
| 119 | ribosome assembly (GO:0042255) | 2.18523801 |
| 120 | regulation of leukocyte degranulation (GO:0043300) | 2.18074795 |
| 121 | urate metabolic process (GO:0046415) | 2.17131778 |
| 122 | mitotic chromosome condensation (GO:0007076) | 2.16625514 |
| 123 | myeloid dendritic cell activation (GO:0001773) | 2.16154928 |
| 124 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.16099862 |
| 125 | response to interferon-alpha (GO:0035455) | 2.15554655 |
| 126 | ribosomal small subunit biogenesis (GO:0042274) | 2.15391135 |
| 127 | natural killer cell mediated immunity (GO:0002228) | 2.15118640 |
| 128 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.15118640 |
| 129 | * protein N-linked glycosylation (GO:0006487) | 2.15067708 |
| 130 | T cell migration (GO:0072678) | 2.14922526 |
| 131 | regulation of protein heterodimerization activity (GO:0043497) | 2.14574536 |
| 132 | maturation of SSU-rRNA (GO:0030490) | 2.14177382 |
| 133 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.13858312 |
| 134 | purine nucleobase biosynthetic process (GO:0009113) | 2.13782441 |
| 135 | pinocytosis (GO:0006907) | 2.13750786 |
| 136 | regulation of podosome assembly (GO:0071801) | 2.13573297 |
| 137 | response to endoplasmic reticulum stress (GO:0034976) | 2.13346666 |
| 138 | one-carbon metabolic process (GO:0006730) | 2.13296776 |
| 139 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.12744136 |
| 140 | pteridine-containing compound metabolic process (GO:0042558) | 2.12452554 |
| 141 | DNA replication initiation (GO:0006270) | 2.12292405 |
| 142 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.11795643 |
| 143 | glycolipid catabolic process (GO:0019377) | 2.10987494 |
| 144 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.10751401 |
| 145 | lymphocyte apoptotic process (GO:0070227) | 2.10716585 |
| 146 | response to fungus (GO:0009620) | 2.10679316 |
| 147 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.09979939 |
| 148 | protein carboxylation (GO:0018214) | 2.09979939 |
| 149 | cortical actin cytoskeleton organization (GO:0030866) | 2.09950673 |
| 150 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.09541893 |
| 151 | detection of molecule of bacterial origin (GO:0032490) | 2.09260473 |
| 152 | IMP metabolic process (GO:0046040) | 2.08860210 |
| 153 | regulation of integrin activation (GO:0033623) | 2.08856182 |
| 154 | regulation of mast cell degranulation (GO:0043304) | 2.08747032 |
| 155 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.08109280 |
| 156 | NADP metabolic process (GO:0006739) | 2.07506140 |
| 157 | definitive hemopoiesis (GO:0060216) | 2.07460184 |
| 158 | wound healing, spreading of epidermal cells (GO:0035313) | 2.07321729 |
| 159 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.06073686 |
| 160 | regulation of response to interferon-gamma (GO:0060330) | 2.05943107 |
| 161 | negative regulation of cell killing (GO:0031342) | 2.05927681 |
| 162 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.05927681 |
| 163 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.05401197 |
| 164 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.05230448 |
| 165 | immunoglobulin mediated immune response (GO:0016064) | 2.04094445 |
| 166 | cellular protein complex disassembly (GO:0043624) | 2.03766650 |
| 167 | defense response to fungus (GO:0050832) | 2.03608161 |
| 168 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.03456995 |
| 169 | necroptotic process (GO:0070266) | 2.02724681 |
| 170 | lysine metabolic process (GO:0006553) | 2.02276377 |
| 171 | lysine catabolic process (GO:0006554) | 2.02276377 |
| 172 | peptide catabolic process (GO:0043171) | 2.02195855 |
| 173 | regulation of tight junction assembly (GO:2000810) | 2.02100294 |
| 174 | neutrophil mediated immunity (GO:0002446) | 2.01853010 |
| 175 | respiratory burst (GO:0045730) | 2.01728309 |
| 176 | positive regulation of tumor necrosis factor production (GO:0032760) | 1.99999717 |
| 177 | regulation of interferon-alpha production (GO:0032647) | 1.99395989 |
| 178 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 1.99382371 |
| 179 | negative regulation of anoikis (GO:2000811) | 1.99183298 |
| 180 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 1.98694046 |
| 181 | oligosaccharide catabolic process (GO:0009313) | 1.98438407 |
| 182 | dendritic cell differentiation (GO:0097028) | 1.97652806 |
| 183 | chronic inflammatory response (GO:0002544) | 1.97545925 |
| 184 | negative regulation of protein localization to plasma membrane (GO:1903077) | 1.96923609 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.65980695 |
| 2 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.29335713 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.22898481 |
| 4 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.76841562 |
| 5 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.74611774 |
| 6 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.52717502 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.43286521 |
| 8 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.34908444 |
| 9 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.34732670 |
| 10 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.18070900 |
| 11 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.11040228 |
| 12 | MYC_22102868_ChIP-Seq_BL_Human | 2.10156323 |
| 13 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.01843212 |
| 14 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.99525154 |
| 15 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.96985295 |
| 16 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.94100239 |
| 17 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.93253659 |
| 18 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.91447188 |
| 19 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.86881901 |
| 20 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.86537337 |
| 21 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.84705661 |
| 22 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.84463046 |
| 23 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.83057833 |
| 24 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.80769706 |
| 25 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.80478264 |
| 26 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.77557466 |
| 27 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.77389558 |
| 28 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.75459184 |
| 29 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.71552827 |
| 30 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.69734762 |
| 31 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.69031366 |
| 32 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.66969316 |
| 33 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.66876488 |
| 34 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.65365581 |
| 35 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.64947931 |
| 36 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.64412321 |
| 37 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.63875663 |
| 38 | GATA1_22025678_ChIP-Seq_K562_Human | 1.63699483 |
| 39 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.62776457 |
| 40 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.62174773 |
| 41 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.62055050 |
| 42 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.61794922 |
| 43 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.61552327 |
| 44 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.60851810 |
| 45 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.60379027 |
| 46 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.58994781 |
| 47 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.57930546 |
| 48 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.57526859 |
| 49 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.57361360 |
| 50 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.56599050 |
| 51 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.55743209 |
| 52 | * VDR_23849224_ChIP-Seq_CD4+_Human | 1.51473382 |
| 53 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.49124601 |
| 54 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.48760953 |
| 55 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.48358158 |
| 56 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.48153290 |
| 57 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.47001190 |
| 58 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.46196656 |
| 59 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.45481084 |
| 60 | * DCP1A_22483619_ChIP-Seq_HELA_Human | 1.44944848 |
| 61 | * FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.43117331 |
| 62 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.42545236 |
| 63 | MYB_26560356_Chip-Seq_TH2_Human | 1.42061590 |
| 64 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.40460587 |
| 65 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.38822062 |
| 66 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.37379078 |
| 67 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.37374985 |
| 68 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.36335665 |
| 69 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.35946485 |
| 70 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.34482011 |
| 71 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.34449521 |
| 72 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.34255933 |
| 73 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.33909765 |
| 74 | MAF_26560356_Chip-Seq_TH1_Human | 1.33048179 |
| 75 | * MYB_26560356_Chip-Seq_TH1_Human | 1.32772608 |
| 76 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.31813301 |
| 77 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.31779130 |
| 78 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.30591458 |
| 79 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.30031528 |
| 80 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.29878064 |
| 81 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.29659476 |
| 82 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.29593899 |
| 83 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.28230070 |
| 84 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.27730475 |
| 85 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.27422934 |
| 86 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.26087869 |
| 87 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.25521361 |
| 88 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.24677353 |
| 89 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.24677353 |
| 90 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.24509441 |
| 91 | MAF_26560356_Chip-Seq_TH2_Human | 1.23866945 |
| 92 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.23860146 |
| 93 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.23708133 |
| 94 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.23076872 |
| 95 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.22736257 |
| 96 | UTX_26944678_Chip-Seq_JUKART_Human | 1.21287983 |
| 97 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.21133738 |
| 98 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.21106078 |
| 99 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.19709533 |
| 100 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.19540699 |
| 101 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.19523153 |
| 102 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.19148318 |
| 103 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.18943780 |
| 104 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.17200287 |
| 105 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.16158106 |
| 106 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.15889848 |
| 107 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.15888824 |
| 108 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.15518064 |
| 109 | * MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.15367556 |
| 110 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.15361855 |
| 111 | * UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.12363790 |
| 112 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.11955910 |
| 113 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.10674499 |
| 114 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.09695742 |
| 115 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.09487006 |
| 116 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09127460 |
| 117 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.07454029 |
| 118 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.07262735 |
| 119 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.07224944 |
| 120 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.06610988 |
| 121 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.05955933 |
| 122 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.05344756 |
| 123 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.04040018 |
| 124 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.03778692 |
| 125 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.03139158 |
| 126 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.01643451 |
| 127 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.01444071 |
| 128 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.01419533 |
| 129 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.01378859 |
| 130 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.01366248 |
| 131 | SPI1_23127762_ChIP-Seq_K562_Human | 1.01209689 |
| 132 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.01066202 |
| 133 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.01034789 |
| 134 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.99650513 |
| 135 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.96735347 |
| 136 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.95612899 |
| 137 | ATF3_27146783_Chip-Seq_COLON_Human | 0.95092346 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005451_abnormal_body_composition | 2.56036078 |
| 2 | MP0006054_spinal_hemorrhage | 2.50669125 |
| 3 | MP0005360_urolithiasis | 2.37200832 |
| 4 | MP0008438_abnormal_cutaneous_collagen | 2.37107534 |
| 5 | MP0002139_abnormal_hepatobiliary_system | 2.31739336 |
| 6 | MP0003300_gastrointestinal_ulcer | 2.27743225 |
| 7 | MP0003705_abnormal_hypodermis_morpholog | 2.25573265 |
| 8 | MP0002396_abnormal_hematopoietic_system | 2.18350071 |
| 9 | MP0003436_decreased_susceptibility_to | 2.13931268 |
| 10 | MP0005058_abnormal_lysosome_morphology | 1.99948579 |
| 11 | MP0001835_abnormal_antigen_presentation | 1.94497945 |
| 12 | MP0003693_abnormal_embryo_hatching | 1.90466855 |
| 13 | MP0010352_gastrointestinal_tract_polyps | 1.90455129 |
| 14 | MP0003303_peritoneal_inflammation | 1.89178721 |
| 15 | MP0005365_abnormal_bile_salt | 1.87683961 |
| 16 | MP0009840_abnormal_foam_cell | 1.86585085 |
| 17 | MP0002166_altered_tumor_susceptibility | 1.84420979 |
| 18 | MP0005623_abnormal_meninges_morphology | 1.77308172 |
| 19 | MP0003091_abnormal_cell_migration | 1.69325951 |
| 20 | MP0005220_abnormal_exocrine_pancreas | 1.68102327 |
| 21 | MP0008004_abnormal_stomach_pH | 1.67185932 |
| 22 | MP0009333_abnormal_splenocyte_physiolog | 1.65887693 |
| 23 | MP0003191_abnormal_cellular_cholesterol | 1.61627592 |
| 24 | MP0003724_increased_susceptibility_to | 1.61474009 |
| 25 | MP0000490_abnormal_crypts_of | 1.61098493 |
| 26 | MP0000685_abnormal_immune_system | 1.60603335 |
| 27 | MP0005464_abnormal_platelet_physiology | 1.60415347 |
| 28 | MP0003806_abnormal_nucleotide_metabolis | 1.58299628 |
| 29 | MP0001666_abnormal_nutrient_absorption | 1.57606930 |
| 30 | MP0004272_abnormal_basement_membrane | 1.50508951 |
| 31 | MP0000343_altered_response_to | 1.50457807 |
| 32 | MP0004957_abnormal_blastocyst_morpholog | 1.47133458 |
| 33 | MP0009785_altered_susceptibility_to | 1.45475138 |
| 34 | MP0002419_abnormal_innate_immunity | 1.44808274 |
| 35 | MP0004808_abnormal_hematopoietic_stem | 1.42851951 |
| 36 | MP0005085_abnormal_gallbladder_physiolo | 1.41285718 |
| 37 | MP0003828_pulmonary_edema | 1.40404501 |
| 38 | MP0003453_abnormal_keratinocyte_physiol | 1.40270371 |
| 39 | MP0005000_abnormal_immune_tolerance | 1.38866649 |
| 40 | MP0005025_abnormal_response_to | 1.37966731 |
| 41 | MP0010368_abnormal_lymphatic_system | 1.37722189 |
| 42 | MP0002877_abnormal_melanocyte_morpholog | 1.36647797 |
| 43 | MP0001533_abnormal_skeleton_physiology | 1.36179231 |
| 44 | MP0005083_abnormal_biliary_tract | 1.34578689 |
| 45 | MP0001873_stomach_inflammation | 1.33356233 |
| 46 | MP0002452_abnormal_antigen_presenting | 1.32047609 |
| 47 | MP0002998_abnormal_bone_remodeling | 1.29726835 |
| 48 | MP0003566_abnormal_cell_adhesion | 1.29407212 |
| 49 | MP0002006_tumorigenesis | 1.28799023 |
| 50 | MP0001800_abnormal_humoral_immune | 1.28130981 |
| 51 | MP0005397_hematopoietic_system_phenotyp | 1.27665526 |
| 52 | MP0001545_abnormal_hematopoietic_system | 1.27665526 |
| 53 | * MP0001845_abnormal_inflammatory_respons | 1.26997923 |
| 54 | MP0010307_abnormal_tumor_latency | 1.25867802 |
| 55 | MP0003186_abnormal_redox_activity | 1.24223640 |
| 56 | MP0002420_abnormal_adaptive_immunity | 1.23763701 |
| 57 | MP0002723_abnormal_immune_serum | 1.23630365 |
| 58 | MP0010155_abnormal_intestine_physiology | 1.23076421 |
| 59 | MP0010234_abnormal_vibrissa_follicle | 1.22729627 |
| 60 | MP0003075_altered_response_to | 1.22589112 |
| 61 | MP0000858_altered_metastatic_potential | 1.21845931 |
| 62 | MP0001819_abnormal_immune_cell | 1.21804993 |
| 63 | MP0003252_abnormal_bile_duct | 1.21753267 |
| 64 | * MP0002398_abnormal_bone_marrow | 1.20993156 |
| 65 | MP0003763_abnormal_thymus_physiology | 1.19368592 |
| 66 | * MP0000689_abnormal_spleen_morphology | 1.18431115 |
| 67 | MP0004947_skin_inflammation | 1.17311177 |
| 68 | MP0005671_abnormal_response_to | 1.17069305 |
| 69 | * MP0008469_abnormal_protein_level | 1.16518774 |
| 70 | MP0005023_abnormal_wound_healing | 1.16518617 |
| 71 | * MP0009643_abnormal_urine_homeostasis | 1.16226285 |
| 72 | MP0000609_abnormal_liver_physiology | 1.14995297 |
| 73 | MP0002405_respiratory_system_inflammati | 1.13445855 |
| 74 | * MP0002722_abnormal_immune_system | 1.13196247 |
| 75 | MP0002138_abnormal_hepatobiliary_system | 1.12927626 |
| 76 | MP0001790_abnormal_immune_system | 1.11834594 |
| 77 | MP0005387_immune_system_phenotype | 1.11834594 |
| 78 | MP0003950_abnormal_plasma_membrane | 1.11126110 |
| 79 | MP0004233_abnormal_muscle_weight | 1.10167532 |
| 80 | * MP0000716_abnormal_immune_system | 1.09280198 |
| 81 | MP0005257_abnormal_intraocular_pressure | 1.09137051 |
| 82 | MP0008875_abnormal_xenobiotic_pharmacok | 1.07652722 |
| 83 | MP0004510_myositis | 1.07650528 |
| 84 | * MP0002429_abnormal_blood_cell | 1.06524428 |
| 85 | MP0005319_abnormal_enzyme/_coenzyme | 1.05084646 |
| 86 | MP0000598_abnormal_liver_morphology | 1.04591181 |
| 87 | MP0009384_cardiac_valve_regurgitation | 1.04163451 |
| 88 | MP0005164_abnormal_response_to | 1.03723911 |
| 89 | MP0003279_aneurysm | 1.02936402 |
| 90 | MP0005332_abnormal_amino_acid | 1.01905306 |
| 91 | MP0001542_abnormal_bone_strength | 1.01749086 |
| 92 | MP0001849_ear_inflammation | 1.01390105 |
| 93 | MP0008007_abnormal_cellular_replicative | 1.01200659 |
| 94 | MP0005275_abnormal_skin_tensile | 1.01191167 |
| 95 | MP0001958_emphysema | 1.01016681 |
| 96 | MP0002148_abnormal_hypersensitivity_rea | 1.00995549 |
| 97 | MP0002933_joint_inflammation | 1.00972997 |
| 98 | MP0005166_decreased_susceptibility_to | 1.00733488 |
| 99 | MP0003172_abnormal_lysosome_physiology | 0.99938575 |
| 100 | MP0008260_abnormal_autophagy | 0.99247115 |
| 101 | MP0003656_abnormal_erythrocyte_physiolo | 0.98952920 |
| 102 | MP0006082_CNS_inflammation | 0.98250415 |
| 103 | MP0000767_abnormal_smooth_muscle | 0.95924640 |
| 104 | MP0005165_increased_susceptibility_to | 0.95477267 |
| 105 | MP0002019_abnormal_tumor_incidence | 0.94887188 |
| 106 | MP0003868_abnormal_feces_composition | 0.94068542 |
| 107 | MP0010329_abnormal_lipoprotein_level | 0.93141267 |
| 108 | MP0009697_abnormal_copulation | 0.91838618 |
| 109 | MP0003077_abnormal_cell_cycle | 0.90980882 |
| 110 | MP0005076_abnormal_cell_differentiation | 0.90315421 |
| 111 | MP0004185_abnormal_adipocyte_glucose | 0.90309583 |
| 112 | MP0009764_decreased_sensitivity_to | 0.89213803 |
| 113 | MP0001853_heart_inflammation | 0.88522667 |
| 114 | MP0010094_abnormal_chromosome_stability | 0.87246247 |
| 115 | MP0003195_calcinosis | 0.87100294 |
| 116 | MP0001661_extended_life_span | 0.86888793 |
| 117 | MP0002060_abnormal_skin_morphology | 0.86340527 |
| 118 | MP0000604_amyloidosis | 0.84980119 |
| 119 | MP0005621_abnormal_cell_physiology | 0.84268406 |
| 120 | MP0003448_altered_tumor_morphology | 0.83870653 |
| 121 | * MP0003795_abnormal_bone_structure | 0.83295201 |
| 122 | MP0003183_abnormal_peptide_metabolism | 0.83013852 |
| 123 | * MP0000465_gastrointestinal_hemorrhage | 0.82279631 |
| 124 | MP0009278_abnormal_bone_marrow | 0.81031268 |
| 125 | MP0001243_abnormal_dermal_layer | 0.80984416 |
| 126 | MP0009763_increased_sensitivity_to | 0.80638391 |
| 127 | MP0000358_abnormal_cell_content/ | 0.80003167 |
| 128 | MP0003221_abnormal_cardiomyocyte_apopto | 0.79992252 |
| 129 | MP0002332_abnormal_exercise_endurance | 0.79224676 |
| 130 | MP0005408_hypopigmentation | 0.77968072 |
| 131 | MP0003111_abnormal_nucleus_morphology | 0.77937071 |
| 132 | MP0001915_intracranial_hemorrhage | 0.77919343 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Thrombocytosis (HP:0001894) | 3.71953523 |
| 2 | Vacuolated lymphocytes (HP:0001922) | 3.35174744 |
| 3 | Protrusio acetabuli (HP:0003179) | 3.16680130 |
| 4 | Abnormality of glycolipid metabolism (HP:0010969) | 3.02414928 |
| 5 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.02414928 |
| 6 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.02414928 |
| 7 | Dysostosis multiplex (HP:0000943) | 2.96318939 |
| 8 | Spinal cord lesions (HP:0100561) | 2.95236560 |
| 9 | Syringomyelia (HP:0003396) | 2.95236560 |
| 10 | Cervical subluxation (HP:0003308) | 2.79353381 |
| 11 | Mucopolysacchariduria (HP:0008155) | 2.72996536 |
| 12 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.72996536 |
| 13 | IgM deficiency (HP:0002850) | 2.72879438 |
| 14 | Premature rupture of membranes (HP:0001788) | 2.68837670 |
| 15 | Abnormality of the common coagulation pathway (HP:0010990) | 2.64727451 |
| 16 | Beaking of vertebral bodies (HP:0004568) | 2.63217995 |
| 17 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.56448907 |
| 18 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.53930333 |
| 19 | Impaired platelet aggregation (HP:0003540) | 2.53545950 |
| 20 | Abnormal platelet function (HP:0011869) | 2.53545950 |
| 21 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.51663677 |
| 22 | Eczematoid dermatitis (HP:0000976) | 2.49796111 |
| 23 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.48827041 |
| 24 | Chronic otitis media (HP:0000389) | 2.48630845 |
| 25 | Abnormal number of erythroid precursors (HP:0012131) | 2.47261599 |
| 26 | Recurrent abscess formation (HP:0002722) | 2.45918809 |
| 27 | Peritonitis (HP:0002586) | 2.40779756 |
| 28 | Recurrent bacterial skin infections (HP:0005406) | 2.38737805 |
| 29 | Hypoglycemic coma (HP:0001325) | 2.35380763 |
| 30 | Petechiae (HP:0000967) | 2.35075342 |
| 31 | Xanthomatosis (HP:0000991) | 2.34164605 |
| 32 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.33092054 |
| 33 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.33092054 |
| 34 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.33092054 |
| 35 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.32687005 |
| 36 | Osteolytic defects of the hand bones (HP:0009699) | 2.32687005 |
| 37 | Nonimmune hydrops fetalis (HP:0001790) | 2.31321935 |
| 38 | Colitis (HP:0002583) | 2.29080209 |
| 39 | Joint stiffness (HP:0001387) | 2.28802457 |
| 40 | Short nail (HP:0001799) | 2.28443041 |
| 41 | Mediastinal lymphadenopathy (HP:0100721) | 2.27477633 |
| 42 | Atrophic scars (HP:0001075) | 2.23823848 |
| 43 | Myositis (HP:0100614) | 2.20643851 |
| 44 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.18664662 |
| 45 | Abnormality of T cell physiology (HP:0011840) | 2.18459543 |
| 46 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.18346408 |
| 47 | Myocardial infarction (HP:0001658) | 2.15697848 |
| 48 | Ankle contracture (HP:0006466) | 2.14982268 |
| 49 | Vertebral compression fractures (HP:0002953) | 2.14972546 |
| 50 | Spinal rigidity (HP:0003306) | 2.14375310 |
| 51 | Interstitial pulmonary disease (HP:0006530) | 2.14095741 |
| 52 | Entropion (HP:0000621) | 2.13079440 |
| 53 | Achilles tendon contracture (HP:0001771) | 2.12811449 |
| 54 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 2.11763324 |
| 55 | Aortic aneurysm (HP:0004942) | 2.10983281 |
| 56 | Deep venous thrombosis (HP:0002625) | 2.10585001 |
| 57 | Hematochezia (HP:0002573) | 2.09886645 |
| 58 | Epistaxis (HP:0000421) | 2.09572589 |
| 59 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 2.08429414 |
| 60 | Wormian bones (HP:0002645) | 2.07890889 |
| 61 | Elbow flexion contracture (HP:0002987) | 2.07700965 |
| 62 | Multiple enchondromatosis (HP:0005701) | 2.05572304 |
| 63 | Spastic diplegia (HP:0001264) | 2.04695043 |
| 64 | * Abnormality of the intrinsic pathway (HP:0010989) | 2.03938949 |
| 65 | Pustule (HP:0200039) | 2.03074156 |
| 66 | Gastrointestinal inflammation (HP:0004386) | 2.02151348 |
| 67 | Blue sclerae (HP:0000592) | 2.02104904 |
| 68 | Spontaneous hematomas (HP:0007420) | 2.01325972 |
| 69 | Aplastic anemia (HP:0001915) | 1.99950355 |
| 70 | Loss of speech (HP:0002371) | 1.99676704 |
| 71 | Cerebral aneurysm (HP:0004944) | 1.99417120 |
| 72 | Inflammation of the large intestine (HP:0002037) | 1.98983851 |
| 73 | Abnormal foot bone ossification (HP:0010675) | 1.98555360 |
| 74 | Severe short stature (HP:0003510) | 1.98076461 |
| 75 | Orchitis (HP:0100796) | 1.97779510 |
| 76 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.96315395 |
| 77 | Flat acetabular roof (HP:0003180) | 1.94225860 |
| 78 | Increased serum ferritin (HP:0003281) | 1.93730238 |
| 79 | Abnormality of the Achilles tendon (HP:0005109) | 1.92954414 |
| 80 | Abnormal platelet volume (HP:0011876) | 1.92911083 |
| 81 | Abnormal cartilage morphology (HP:0002763) | 1.92834180 |
| 82 | Recurrent viral infections (HP:0004429) | 1.92480275 |
| 83 | Nasal polyposis (HP:0100582) | 1.92465278 |
| 84 | Hypertensive crisis (HP:0100735) | 1.92098252 |
| 85 | Reticulocytopenia (HP:0001896) | 1.91287520 |
| 86 | Cellulitis (HP:0100658) | 1.90115547 |
| 87 | Abnormality of the nasal mucosa (HP:0000433) | 1.89942045 |
| 88 | Abnormality of carpal bone ossification (HP:0006257) | 1.89710174 |
| 89 | Mitral stenosis (HP:0001718) | 1.89135274 |
| 90 | Multiple lipomas (HP:0001012) | 1.88851143 |
| 91 | Aortic dissection (HP:0002647) | 1.88781752 |
| 92 | Gout (HP:0001997) | 1.88109293 |
| 93 | Abnormality of iron homeostasis (HP:0011031) | 1.87989648 |
| 94 | Microretrognathia (HP:0000308) | 1.87947491 |
| 95 | Fatigue (HP:0012378) | 1.87451140 |
| 96 | Upper motor neuron abnormality (HP:0002127) | 1.87252926 |
| 97 | Gastrointestinal infarctions (HP:0005244) | 1.86785548 |
| 98 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.86080402 |
| 99 | Bone pain (HP:0002653) | 1.85929473 |
| 100 | Hepatosplenomegaly (HP:0001433) | 1.84943931 |
| 101 | Abnormality of macrophages (HP:0004311) | 1.84612562 |
| 102 | Thrombophlebitis (HP:0004418) | 1.84316134 |
| 103 | Menorrhagia (HP:0000132) | 1.83919451 |
| 104 | Vascular tortuosity (HP:0004948) | 1.83896259 |
| 105 | IgA deficiency (HP:0002720) | 1.83376249 |
| 106 | Poor head control (HP:0002421) | 1.81511925 |
| 107 | Abnormality of the peritoneum (HP:0002585) | 1.80832772 |
| 108 | Abnormality of purine metabolism (HP:0004352) | 1.80497118 |
| 109 | Genu recurvatum (HP:0002816) | 1.79555956 |
| 110 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.78806504 |
| 111 | Increased mean platelet volume (HP:0011877) | 1.77808508 |
| 112 | Fragile skin (HP:0001030) | 1.77448880 |
| 113 | Thin bony cortex (HP:0002753) | 1.77288986 |
| 114 | Generalized aminoaciduria (HP:0002909) | 1.77255624 |
| 115 | Abnormality of subcutaneous fat tissue (HP:0001001) | 1.76074481 |
| 116 | Intrahepatic cholestasis (HP:0001406) | 1.75780175 |
| 117 | Arterial tortuosity (HP:0005116) | 1.75429910 |
| 118 | Arterial thrombosis (HP:0004420) | 1.75327936 |
| 119 | Abnormal ossification of hand bones (HP:0005921) | 1.75043868 |
| 120 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.74742707 |
| 121 | Biconcave vertebral bodies (HP:0004586) | 1.74573209 |
| 122 | Polycythemia (HP:0001901) | 1.74284258 |
| 123 | Hypobetalipoproteinemia (HP:0003563) | 1.73844141 |
| 124 | Purpura (HP:0000979) | 1.73562925 |
| 125 | Abnormality of complement system (HP:0005339) | 1.73317660 |
| 126 | Gingival bleeding (HP:0000225) | 1.71460677 |
| 127 | Vasculitis (HP:0002633) | 1.70835199 |
| 128 | Increased density of long bones (HP:0006392) | 1.70003610 |
| 129 | Abnormality of T cells (HP:0002843) | 1.69794366 |
| 130 | Spondylolisthesis (HP:0003302) | 1.68905780 |
| 131 | Short clavicles (HP:0000894) | 1.68902782 |
| 132 | Increased cerebral lipofuscin (HP:0011813) | 1.67762793 |
| 133 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.67729289 |
| 134 | Abnormality of nucleobase metabolism (HP:0010932) | 1.67727215 |
| 135 | Abnormality of the umbilical cord (HP:0010881) | 1.66844136 |
| 136 | Fat malabsorption (HP:0002630) | 1.66798149 |
| 137 | Abnormal tarsal ossification (HP:0008369) | 1.66622190 |
| 138 | Recurrent bronchitis (HP:0002837) | 1.66244268 |
| 139 | Abnormality of the acetabulum (HP:0003170) | 1.66076193 |
| 140 | Radial bowing (HP:0002986) | 1.65721251 |
| 141 | Tetraparesis (HP:0002273) | 1.65418562 |
| 142 | Rough bone trabeculation (HP:0100670) | 1.65025412 |
| 143 | Dilatation of the ascending aorta (HP:0005111) | 1.64678716 |
| 144 | Amyloidosis (HP:0011034) | 1.64420259 |
| 145 | Chronic obstructive pulmonary disease (HP:0006510) | 1.64062365 |
| 146 | Obstructive lung disease (HP:0006536) | 1.64062365 |
| 147 | Generalized amyotrophy (HP:0003700) | 1.64003561 |
| 148 | Elevated alkaline phosphatase (HP:0003155) | 1.63567150 |
| 149 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.62276574 |
| 150 | Systemic lupus erythematosus (HP:0002725) | 1.61450790 |
| 151 | Macrocytic anemia (HP:0001972) | 1.61418311 |
| 152 | Polygenic inheritance (HP:0010982) | 1.60887633 |
| 153 | Gastrointestinal stroma tumor (HP:0100723) | 1.60829370 |
| 154 | Conjunctival telangiectasia (HP:0000524) | 1.60314301 |
| 155 | Recurrent skin infections (HP:0001581) | 1.60226398 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 3.48648393 |
| 2 | PRPF4B | 3.47895278 |
| 3 | NME2 | 3.25274449 |
| 4 | SCYL2 | 2.97757696 |
| 5 | EIF2AK3 | 2.82061175 |
| 6 | PKN2 | 2.80832214 |
| 7 | TRIB3 | 2.52868037 |
| 8 | FLT3 | 2.31671458 |
| 9 | TAOK2 | 2.18111033 |
| 10 | EEF2K | 2.14673146 |
| 11 | BCKDK | 2.14301833 |
| 12 | MAP4K1 | 2.05822258 |
| 13 | SMG1 | 1.93234708 |
| 14 | PIM2 | 1.85772294 |
| 15 | LATS1 | 1.81951173 |
| 16 | WEE1 | 1.78277951 |
| 17 | ZAP70 | 1.73722739 |
| 18 | JAK3 | 1.69910175 |
| 19 | ACVR1B | 1.65989647 |
| 20 | TAOK3 | 1.63695350 |
| 21 | LRRK2 | 1.62259903 |
| 22 | KDR | 1.60741306 |
| 23 | EIF2AK1 | 1.60186596 |
| 24 | ARAF | 1.59467299 |
| 25 | MAP2K3 | 1.58221244 |
| 26 | MOS | 1.56061512 |
| 27 | KIT | 1.55765223 |
| 28 | STK10 | 1.52578704 |
| 29 | TBK1 | 1.52280648 |
| 30 | TYK2 | 1.48773891 |
| 31 | TEC | 1.45074414 |
| 32 | BTK | 1.43758514 |
| 33 | RPS6KA4 | 1.43375535 |
| 34 | MAP3K3 | 1.43127827 |
| 35 | MAP3K10 | 1.43109143 |
| 36 | TESK2 | 1.42063120 |
| 37 | BLK | 1.40552853 |
| 38 | BUB1 | 1.36883579 |
| 39 | MAP3K13 | 1.30145093 |
| 40 | BRSK2 | 1.30100607 |
| 41 | TGFBR2 | 1.24682448 |
| 42 | NEK9 | 1.21139582 |
| 43 | NEK2 | 1.21052475 |
| 44 | PASK | 1.19001839 |
| 45 | DDR2 | 1.18322731 |
| 46 | PAK4 | 1.17651071 |
| 47 | CDK12 | 1.13004484 |
| 48 | CSF1R | 1.12299156 |
| 49 | PIK3CG | 1.11336681 |
| 50 | FRK | 1.10095744 |
| 51 | MAP3K8 | 1.05845926 |
| 52 | DYRK3 | 1.05756577 |
| 53 | RPS6KB2 | 1.02590874 |
| 54 | ICK | 1.01960052 |
| 55 | TESK1 | 1.01271122 |
| 56 | FGFR4 | 1.00783494 |
| 57 | PTK6 | 1.00540014 |
| 58 | MYLK | 0.99411318 |
| 59 | PIM1 | 0.98163906 |
| 60 | IRAK4 | 0.97711169 |
| 61 | TGFBR1 | 0.96762000 |
| 62 | CDK4 | 0.95161925 |
| 63 | CDC7 | 0.95023040 |
| 64 | MAP3K1 | 0.94476254 |
| 65 | MAPKAPK3 | 0.91026388 |
| 66 | IRAK3 | 0.87696438 |
| 67 | TTN | 0.87455249 |
| 68 | PAK2 | 0.87060396 |
| 69 | DAPK3 | 0.86722918 |
| 70 | ITK | 0.85899578 |
| 71 | CLK1 | 0.84893201 |
| 72 | LATS2 | 0.82798329 |
| 73 | MAP3K11 | 0.82469934 |
| 74 | STK3 | 0.81946431 |
| 75 | GRK7 | 0.81706179 |
| 76 | BMPR2 | 0.80765349 |
| 77 | MST1R | 0.80579634 |
| 78 | ABL2 | 0.77016627 |
| 79 | PBK | 0.75711192 |
| 80 | GRK6 | 0.73377689 |
| 81 | NLK | 0.72180589 |
| 82 | MATK | 0.70961896 |
| 83 | MAP3K6 | 0.70402033 |
| 84 | MELK | 0.69976284 |
| 85 | ERBB4 | 0.69520206 |
| 86 | CSK | 0.69506820 |
| 87 | CDK6 | 0.67980848 |
| 88 | JAK2 | 0.67928963 |
| 89 | SYK | 0.66448479 |
| 90 | STK16 | 0.65691035 |
| 91 | CDC42BPA | 0.63901290 |
| 92 | SIK1 | 0.63733735 |
| 93 | LCK | 0.63148208 |
| 94 | LYN | 0.63052625 |
| 95 | CAMKK2 | 0.62412207 |
| 96 | IRAK2 | 0.61584425 |
| 97 | BRAF | 0.60089002 |
| 98 | AURKB | 0.59618853 |
| 99 | JAK1 | 0.59511375 |
| 100 | RPS6KL1 | 0.59276278 |
| 101 | RPS6KC1 | 0.59276278 |
| 102 | MAP2K2 | 0.59150873 |
| 103 | IKBKE | 0.58766644 |
| 104 | CCNB1 | 0.58054925 |
| 105 | RPS6KA5 | 0.58000339 |
| 106 | TAOK1 | 0.57594321 |
| 107 | IKBKB | 0.56557971 |
| 108 | MAPK11 | 0.55359933 |
| 109 | CDK7 | 0.55168998 |
| 110 | PDGFRA | 0.55043574 |
| 111 | FGR | 0.53094119 |
| 112 | TIE1 | 0.52981371 |
| 113 | RIPK1 | 0.51878263 |
| 114 | MET | 0.50836784 |
| 115 | EPHA2 | 0.49941098 |
| 116 | LIMK1 | 0.49599353 |
| 117 | FES | 0.49426312 |
| 118 | HCK | 0.49245744 |
| 119 | MAP3K14 | 0.48511777 |
| 120 | TAF1 | 0.47561393 |
| 121 | RPS6KA2 | 0.47379737 |
| 122 | EPHB1 | 0.47263581 |
| 123 | CDK9 | 0.46957615 |
| 124 | DAPK1 | 0.46392743 |
| 125 | PTK2 | 0.45854782 |
| 126 | RAF1 | 0.45148305 |
| 127 | CDK8 | 0.45080837 |
| 128 | MAP3K5 | 0.41423039 |
| 129 | MARK3 | 0.41133578 |
| 130 | STK4 | 0.39458494 |
| 131 | MAP3K2 | 0.38074618 |
| 132 | VRK1 | 0.37841364 |
| 133 | DYRK1B | 0.35352278 |
| 134 | PRKG2 | 0.35174898 |
| 135 | ILK | 0.34883316 |
| 136 | TRPM7 | 0.33961957 |
| 137 | TXK | 0.32838769 |
| 138 | ABL1 | 0.32823412 |
| 139 | ATR | 0.31036317 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Protein export_Homo sapiens_hsa03060 | 2.74560199 |
| 2 | DNA replication_Homo sapiens_hsa03030 | 2.46320832 |
| 3 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 2.25623803 |
| 4 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.17061488 |
| 5 | Selenocompound metabolism_Homo sapiens_hsa00450 | 2.01166309 |
| 6 | Ribosome_Homo sapiens_hsa03010 | 1.97876543 |
| 7 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.92346289 |
| 8 | Other glycan degradation_Homo sapiens_hsa00511 | 1.83195413 |
| 9 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.71476889 |
| 10 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.68495886 |
| 11 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.63881033 |
| 12 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.61569941 |
| 13 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.56998163 |
| 14 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.56268904 |
| 15 | Sulfur relay system_Homo sapiens_hsa04122 | 1.56227092 |
| 16 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.56176359 |
| 17 | * N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.54821248 |
| 18 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.46817965 |
| 19 | Allograft rejection_Homo sapiens_hsa05330 | 1.46127622 |
| 20 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.43565035 |
| 21 | Viral myocarditis_Homo sapiens_hsa05416 | 1.40042781 |
| 22 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.39215238 |
| 23 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.36159151 |
| 24 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.30845029 |
| 25 | Legionellosis_Homo sapiens_hsa05134 | 1.27956418 |
| 26 | Salmonella infection_Homo sapiens_hsa05132 | 1.27940171 |
| 27 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.27303783 |
| 28 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.25504268 |
| 29 | Lysosome_Homo sapiens_hsa04142 | 1.24140999 |
| 30 | Proteasome_Homo sapiens_hsa03050 | 1.21491157 |
| 31 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.20787941 |
| 32 | Mismatch repair_Homo sapiens_hsa03430 | 1.20153277 |
| 33 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.17950739 |
| 34 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.17397993 |
| 35 | Leishmaniasis_Homo sapiens_hsa05140 | 1.17144912 |
| 36 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.16653611 |
| 37 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.14417922 |
| 38 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.11735321 |
| 39 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.11418432 |
| 40 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.11011853 |
| 41 | Hepatitis C_Homo sapiens_hsa05160 | 1.10858490 |
| 42 | Base excision repair_Homo sapiens_hsa03410 | 1.09358447 |
| 43 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.09006134 |
| 44 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.07324487 |
| 45 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.06054777 |
| 46 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.04047915 |
| 47 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.03539837 |
| 48 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.02680879 |
| 49 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.01932481 |
| 50 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.99737791 |
| 51 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.99587844 |
| 52 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.97667470 |
| 53 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.96621621 |
| 54 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.95190519 |
| 55 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.94877514 |
| 56 | Prion diseases_Homo sapiens_hsa05020 | 0.93053051 |
| 57 | Cell cycle_Homo sapiens_hsa04110 | 0.91984037 |
| 58 | HTLV-I infection_Homo sapiens_hsa05166 | 0.90915197 |
| 59 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.90511566 |
| 60 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.90452668 |
| 61 | Apoptosis_Homo sapiens_hsa04210 | 0.89637453 |
| 62 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.89062154 |
| 63 | Asthma_Homo sapiens_hsa05310 | 0.89054533 |
| 64 | RNA transport_Homo sapiens_hsa03013 | 0.88617024 |
| 65 | Shigellosis_Homo sapiens_hsa05131 | 0.87794141 |
| 66 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.86772709 |
| 67 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.86010241 |
| 68 | Amoebiasis_Homo sapiens_hsa05146 | 0.85336065 |
| 69 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.85285359 |
| 70 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.85095864 |
| 71 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.84853870 |
| 72 | Galactose metabolism_Homo sapiens_hsa00052 | 0.83989406 |
| 73 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.83930835 |
| 74 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.83079386 |
| 75 | Focal adhesion_Homo sapiens_hsa04510 | 0.83033405 |
| 76 | Measles_Homo sapiens_hsa05162 | 0.80094220 |
| 77 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.80054685 |
| 78 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.79639923 |
| 79 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.79351336 |
| 80 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.77694956 |
| 81 | Malaria_Homo sapiens_hsa05144 | 0.77360476 |
| 82 | RNA polymerase_Homo sapiens_hsa03020 | 0.76143445 |
| 83 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.75733588 |
| 84 | Carbon metabolism_Homo sapiens_hsa01200 | 0.74568346 |
| 85 | Homologous recombination_Homo sapiens_hsa03440 | 0.73956122 |
| 86 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.73821655 |
| 87 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.72716519 |
| 88 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.72279910 |
| 89 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.71950619 |
| 90 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.71702330 |
| 91 | Spliceosome_Homo sapiens_hsa03040 | 0.71568585 |
| 92 | Peroxisome_Homo sapiens_hsa04146 | 0.70580845 |
| 93 | Pertussis_Homo sapiens_hsa05133 | 0.70540626 |
| 94 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.70438020 |
| 95 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.70355077 |
| 96 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.69052778 |
| 97 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.68733101 |
| 98 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.68533768 |
| 99 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.67723791 |
| 100 | Hepatitis B_Homo sapiens_hsa05161 | 0.67564714 |
| 101 | Prostate cancer_Homo sapiens_hsa05215 | 0.66845260 |
| 102 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.65419307 |
| 103 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.64898090 |
| 104 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.64766000 |
| 105 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.63806941 |
| 106 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.63769264 |
| 107 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.63586269 |
| 108 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.62646630 |
| 109 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.62042966 |
| 110 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.61814342 |
| 111 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.61653531 |
| 112 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.61280485 |
| 113 | Thyroid cancer_Homo sapiens_hsa05216 | 0.61137063 |
| 114 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.60620449 |
| 115 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.60587743 |
| 116 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.59846858 |
| 117 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.59727903 |
| 118 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.59432562 |
| 119 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.58860667 |
| 120 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.57555919 |
| 121 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.57412203 |
| 122 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.56420287 |
| 123 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.55024532 |
| 124 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.54708378 |
| 125 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.54049443 |
| 126 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.52993864 |
| 127 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.52169402 |
| 128 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.51581740 |
| 129 | Histidine metabolism_Homo sapiens_hsa00340 | 0.51467531 |
| 130 | Bladder cancer_Homo sapiens_hsa05219 | 0.50658681 |
| 131 | Platelet activation_Homo sapiens_hsa04611 | 0.50446864 |
| 132 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.49552741 |
| 133 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.49040507 |
| 134 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.48739770 |
| 135 | Influenza A_Homo sapiens_hsa05164 | 0.47483915 |
| 136 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.47345249 |
| 137 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.47170670 |
| 138 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.47110407 |
| 139 | Alcoholism_Homo sapiens_hsa05034 | 0.45660584 |
| 140 | Tuberculosis_Homo sapiens_hsa05152 | 0.45574950 |
| 141 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.45503515 |
| 142 | Phagosome_Homo sapiens_hsa04145 | 0.45377485 |
| 143 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.44998933 |
| 144 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.43623475 |

